Impact of COVID-19 on Management and Outcomes of Oncology Patients: Results of MENA COVID-19 and Cancer Registry (MCCR).
Abdul Rahman JaziehAdda BounedjarHikmat Abdel-RazeqElif Berna KoksoyJawaher AnsariArafat H TfayliEmad M TashkandiWasil A JastaniahMohamed Osama AlorabiAmira D DarwishAhmed Magdy RabeaAshwaq Al OlayanFahad IbnshamsahHassan ErrihaniMohammad Omar AlKaiyatFazal HussainKhaled AlkattanSuanna Steeby BruinoogeElizabeth Garrett-MayerHani TamimPublished in: Journal of immunotherapy and precision oncology (2024)
Patients with cancer in the MENA region experienced similar risks and outcome of COVID-19 as reported in other populations. Although there were fewer treatment delays after June 1, 2020, 90-day mortality increased, which may be attributed to other risk factors such as disease progression or new patients who presented with more advanced disease.
Keyphrases
- coronavirus disease
- sars cov
- risk factors
- end stage renal disease
- newly diagnosed
- ejection fraction
- chronic kidney disease
- respiratory syndrome coronavirus
- palliative care
- papillary thyroid
- peritoneal dialysis
- cardiovascular events
- risk assessment
- human health
- squamous cell
- combination therapy
- patient reported
- weight loss
- smoking cessation